View Author
patient scale study score group disability value measure treatment outcome change strength polyneuropathy trial outcome measures demyelinating neuropathy responsiveness neurology polyneuropathie motor guillain-barre syndrome handicap validity reliability nerve fatigue incat immune-mediated neurol assessment igiv-c health grip strength impairment range immune-mediated polyneuropathies syndrome table improvement placebo sumscore vibration demyelinating polyneuropathy correlation level baseline symptom guillain-barre flammatory demyelinating polyradiculoneuropathy muscle regression disease condition hughe result effect activity neuropathy cause incat disability score grade signi method evaluation flammatory -36 rotterdam model schmitz pim globulin quality measurement chapter association mgusp clinimetric neuropathie couple fi rst period control
10 Most Recent Publications
|
Revised normative values for grip strength with the Jamar dynamometer
(Article)
Peters, M.J.H. Nes, S.I. van Vanhoutte, E.K. Bakkers, M. Doorn, P.A. van Merkies, I.S.J. Faber, C.G. |
2011-03-01
|
|
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
(Article)
Nes, S.I. van Vanhoutte, E.K. Doorn, P.A. van Hermans, M.C.E. Bakkers, M. Kuitwaard, K. Faber, C.G. Merkies, I.S.J. |
2011-01-25
|
|
Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy
(Article)
Bakkers, M. Faber, C.G. Drent, M. Hermans, M.C.E. Nes, S.I. van Lauria, G. Baets, M. de Merkies, I.S.J. |
2010-12-01
|
|
Chronic inflammatory demyelinating polyneuropathy disease activity status: Recommendations for clinical research standards and use in clinical practice
(Article)
Gorson, K.C. Schaik, I.N. van Goldstein, J. Katz, J. Graves, M. Parry, G. Doorn, P.A. van Merkies, I.S.J. Lewis, R.A. Barohn, R.J. Koski, C.L. Cornblath, D.R. Hughes, R.A.C. Hahn, A.F. Baumgarten, M. |
2010-12-01
|
|
Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: Shifting from statistical significance to clinical relevance
(Article)
Merkies, I.S.J. Nes, S.I. van Hanna, K. Hughes, R.A.C. Deng, C. |
2010-11-01
|
|
Electrophysiologic correlations with clinical outcomes in CIDP
(Article)
Bril, V. Banach, M. Merkies, I.S.J. Doorn, P.A. van Dalakas, M.C. Deng, C. Donofrio, P. Hanna, K. Hartung, H.P. Hughes, R.A.C. Katzberg, H. Latov, N. |
2010-10-01
|
|
The measurement of disease
(Article)
Merkies, I.S.J. Hughes, R.A.C. |
2010-09-01
|
|
Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy
(Article)
Donofrio, P. Bril, V. Dalakas, M.C. Deng, C. Hanna, K. Hartung, H.P. Hughes, R.A.C. Latov, N. Merkies, I.S.J. Doorn, P.A. van |
2010-09-01
|
|
Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
(Article)
Latov, N. Deng, C. Dalakas, M.C. Bril, V. Donofrio, P. Hanna, K. Hartung, H.P. Hughes, R.A.C. Merkies, I.S.J. Doorn, P.A. van |
2010-07-01
|
|
Improving fatigue assessment in immune-mediated neuropathies: The modified Rasch-built fatigue severity scale
(Article)
Nes, S.I. van Vanhoutte, E.K. Faber, C.G. Garssen, M.P.J. Doorn, P.A. van Merkies, I.S.J. |
2009-12-01
|